Physician

Dewitt Charles Fortenberry, MD

According to 2025 Medicare claims, Dewitt Fortenberry, MD (NPI: 1114960473) practices internal medicine in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is MEDEVAL, LLC (NPI: 1740548346; TIN: 262029002) and primary practice location at 75503-9998.

Fortenberry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 3,612 HCPCS/CPT codes, and received $305,265 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,482 prescription claims across 193 beneficiaries totaling $351,227 in drug costs, led by Eliquis (Apixaban). DME data shows 710 claims. Open Payments data shows 2 records totaling $48. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $27,929 to $351,227. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $25,635 to $41,351.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	456	3,295	$256,177
2016	456	3,662	$301,130
2017	500	3,942	$329,924
2018	431	3,563	$302,898
2019	422	3,922	$338,303
2020	406	4,028	$335,181
2021	428	3,954	$340,780
2022	449	4,442	$374,913
2023	369	3,815	$358,186
2024	385	3,612	$305,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	282	$27,929
2016	48	141	$17,353
2017	65	282	$15,307
2018	57	173	$7,039
2019	86	183	$7,320
2020	69	116	$15,397
2021	66	94	$13,994
2022	73	99	$3,365
2023	174	1,800	$110,608
2024	193	3,482	$351,227

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	129	381	$22,319
2016	137	465	$15,675
2017	86	334	$9,133
2018	114	465	$11,301
2019	131	594	$75,127
2020	182	867	$25,739
2021	289	1,203	$54,644
2022	269	1,093	$44,469
2023	340	1,143	$54,514
2024	179	710	$34,564

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	313	345	$119
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	363	2,905	$81
99239	Hospital discharge day management, more than 30 minutes	230	243	$78
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	12	75	$74

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	226	3,175	$67,369
Nuplazid	Pimavanserin Tartrate	11	154	$27,341
Invega Sustenna	Paliperidone Palmitate	13	390	$16,037
Ozempic	Semaglutide	13	396	$13,496
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	226	$10,167

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$11,961
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	48	$4,477
K0001	Standard wheelchair	Y	40	210	$4,339
E2611	General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware	N	18	18	$2,945
E0143	Walker, folding, wheeled, adjustable or fixed height	N	48	48	$2,504

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$48	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dewitt Charles Fortenberry, MD?

Tedicare shows public-source Medicare data for Dewitt Charles Fortenberry, MD (NPI 1114960473), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dewitt Charles Fortenberry, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dewitt Charles Fortenberry, MD?

Dewitt Charles Fortenberry, MD is linked to MEDEVAL, LLC (billing NPI 1740548346) in the available physician profile data.

Does Dewitt Charles Fortenberry, MD have Open Payments data?

Dewitt Charles Fortenberry, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.